| Literature DB >> 32155772 |
Damian Piotrowski1, Anna Sączewska-Piotrowska2, Jerzy Jaroszewicz1, Anna Boroń-Kaczmarska3.
Abstract
Background and aim: The aim of this study was to assess the diagnostic performance of new morphology-related indices and Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores during hospitalization in predicting the onset of bacterial infection in patients with liver cirrhosis. Material and methods: A total of 171 patients (56.9% males; median age 59 years; total number of hospitalizations 209) with liver cirrhosis were included in this observational study. The diagnosis of cirrhosis was made on the basis of clinical, biochemical, ultrasonic, histological, and endoscopic findings. The neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), modified aspartate aminotransferase-to-platelet ratio index (APRI), aspartate aminotransferase-to-alanine aminotransferase ratio (AAR), Fibrosis-4 index (FIB-4), platelet-to-lymphocyte ratio (PLR), neutrophil-to-monocyte ratio (NMR), and CTP and MELD scores were calculated for the cases of patients with cirrhosis.Entities:
Keywords: LMR; bacterial infections; community-acquired infections; liver cirrhosis; logistic regression; nosocomial infections; risk assessment
Year: 2020 PMID: 32155772 PMCID: PMC7084714 DOI: 10.3390/ijerph17051727
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Indices calculated using widely available parameters.
| Calculated Indices | First Publication | Required Parameters | Formula |
|---|---|---|---|
| AAR | Williams, Hoofnagle (1988) [ | AST, ALT |
|
| Modified APRI | Fix et al. (2005) [ | albumin, AST, PLT, age |
|
| FIB-4 | Sterling et al. (2006) [ | ALT, AST, PLT, age |
|
| NLR | Zahorec R (2001) [ | neutrophil, lymphocyte |
|
| LMR | Merekoulias G et al. (2010) [ | lymphocyte, monocyte |
|
| PLR | Turkmen K et al. (2013) [ | PLT, lymphocyte |
|
| NMR | Cihan YB et al. (2013) [ | neutrophil, monocyte |
|
| CTP | Pugh et al. (1973) [ | bilirubin, albumin, prothrombin time, ascites, encephalopathy | a |
| MELD | Bambha K et al. (2004) [ | creatinine, bilirubin, INR | b |
AAR—aspartate aminotransferase-to-alanine aminotransferase ratio; ALT—alanine aminotransferase, AST—asparagine aminotransferase, APRI—aspartate aminotransferase-to-platelet ratio index, PLT—platelet count, FIB-4—Fibrosis-4 index; NLR—neutrophil-to-lymphocyte ratio; LMR—lymphocyte-to-monocyte ratio; PLR—platelet-to-lymphocyte ratio; NMR—neutrophil-to-monocyte ratio; CTP—Child-Turcotte-Pugh; MELD—Model for End-Stage Liver Disease, INR—international normalized ratio; a—Child-Turcotte-Pugh (CTP) score consists of three objective symptoms of liver failure (serum bilirubin and albumin concentrations, prothrombin time) and two subjective symptoms (presence of ascites and encephalopathy). The CTP score ranges between 5 and 15 points, wherein three classes are distinguished: class A (5 to 6 points), class B (7 to 9 points), and class C (10 to 15 points). b— ; creatinine and bilirubin concentrations are in mg/dL. The computed score is rounded to an integer. If any of the laboratory parameters are lower than 1.0, it should be set to 1.0 for input for the formula to avoid generating a negative score. The maximum Model for End-Stage Liver Disease (MELD) score is 40. Any results higher than 40 are adjusted to 40 [13].
The bacteria identified in diagnosed infections.
| Infection Type | Infectious Agent | Number of Cases |
|---|---|---|
| UTI |
| 32 (53.3%) |
| Pneumonia |
| 1 (1.7%) |
| Sepsis |
| 3 (5.0%) |
| SBP |
| 1 (1.7%) |
| Infected post-operative wound |
| 1 (1.7%) |
| Abscess of subcutaneous tissue |
| 2 (3.3%) |
UTI—urinary tract infection; SBP—spontaneous bacterial peritonitis.
Median and lower-upper quartile range of laboratory and clinical results in two groups of patients: with and without infection.
| Parameter | Presence of Infection | Lack of Infection |
|
|---|---|---|---|
| NLR | 2.45 (1.45–6.00) | 1.85 (1.30–3.01) | 0.024 a |
| LMR | 1.43 (1.06–2.01) | 2.59 (1.73–3.84) | <0.001 c |
| PLR | 91.5 (58.8–118.6) | 73.2 (50.8–99.6) | 0.047 a |
| NMR | 5.00 (3.64–7.52) | 4.87 (3.72–7.33) | 0.988 |
| Monocytes [G/L] | 0.70 (0.42–1.02) | 0.54 (0.36–0.75) | 0.011 a |
| AAR | 1.88 (1.41–2.49) | 1.57 (0.98–2.01) | 0.014 a |
| Modified APRI | 15.86 (7.82–30.85) | 12.18 (6.58–31.76) | 0.755 |
| FIB-4 | 6.25 (2.99–10.72) | 6.37 (3.30–12.03) | 0.960 |
| CRP [mg/L] | 30.7 (9.2–40.6) | 6.5 (2.1–29.6) | 0.020 a |
| CTP | 10 (8–11) | 8 (6–9) | <0.001 c |
| MELD | 15 (12–22) | 13 (10–17) | 0.006 b |
a—p < 0.05, b—p < 0.01, c—p < 0.001. NLR—neutrophil-to-lymphocyte ratio; LMR—lymphocyte-to-monocyte ratio; PLR—platelet-to-lymphocyte ratio; NMR—neutrophil-to-monocyte ratio; AAR—aspartate aminotransferase-to-alanine aminotransferase ratio; APRI—aspartate aminotransferase-to-platelet ratio index; FIB-4—Fibrosis-4 index; CRP—C-reactive protein; CTP—Child-Turcotte-Pugh; MELD—Model for End-Stage Liver Disease.
Figure 1Receiver operating characteristics (ROC) curves. NLR—neutrophil-to-lymphocyte ratio; LMR—lymphocyte-to-monocyte ratio; AAR—aspartate aminotransferase-to-alanine aminotransferase ratio; CRP—C-reactive protein; CTP—Child-Turcotte-Pugh; MELD—Model for End-Stage Liver Disease.
Area under the curve (AUC), cutoff values, Se, Sp, positive predictive value (PPV), and negative predictive value (NPV) for statistically significant parameters.
| Parameter | AUC |
| Cut-Off | Se | Sp | PPV | NPV |
|---|---|---|---|---|---|---|---|
| NLR | 0.606 | 0.033 a | 3.96 | 0.434 | 0.860 | 0.561 | 0.787 |
| LMR | 0.715 | <0.001 c | 2.06 | 0.676 | 0.758 | 0.899 | 0.424 |
| Monocytes | 0.648 | 0.010 a | 0.91 | 0.455 | 0.867 | 0.517 | 0.835 |
| AAR | 0.610 | 0.013 a | 2.11 | 0.417 | 0.797 | 0.472 | 0.759 |
| CRP | 0.685 | 0.010 a | 9.2 | 0.760 | 0.600 | 0.613 | 0.750 |
| CTP | 0.687 | <0.001 c | 9.0 | 0.702 | 0.639 | 0.485 | 0.816 |
| MELD | 0.629 | 0.005 b | 18 | 0.439 | 0.783 | 0.500 | 0.738 |
a—p < 0.05, b—p < 0.01, c—p < 0.001. NLR—neutrophil-to-lymphocyte ratio; LMR—lymphocyte-to-monocyte ratio; AAR—aspartate aminotransferase-to-alanine aminotransferase ratio; CRP—C-reactive protein; CTP—Child-Turcotte-Pugh; MELD—Model for End-Stage Liver Disease.
Odds ratio for selected predictors.
| Univariate | Multivariate | |||||||
|---|---|---|---|---|---|---|---|---|
| Predictor | Odds Ratio | CI |
| Nagelkerke’s R2 | Odds Ratio | CI |
| Nagelkerke’s R2 |
| LMR | 0.15 | 0.06–0.37 | <0.001 c | 0.199 | 0.22 | 0.08–0.64 | 0.005 b | 0.251 |
| MONO | 5.42 | 2.23–13.15 | <0.001 c | 0.144 | ||||
| NLR | 4.38 | 2.09–9.17 | <0.001 c | 0.116 | ||||
| CRP | 3.86 | 1.24–12.04 | 0.020 a | 0.133 | ||||
| CTP | 3.17 | 1.52–6.62 | 0.002 b | 0.090 | 2.77 | 1.01–7.60 | 0.048 a | |
| MELD | 3.18 | 1.54–6.56 | 0.002 b | 0.077 | ||||
| AAR | 2.68 | 1.39–5.18 | 0.003 b | 0.060 | ||||
a—p < 0.05, b—p < 0.01, c—p < 0.001.